Gene · 7402
Papers3,966
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,966
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines. | Cancer Sci | 2023 | 37700464 | PubTator, text mining | PubMed |
| CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy. | Mol Ther Methods Clin Dev | 2023 | 37693945 | PubTator, text mining | PubMed |
| Enrichment of carcinogen-driven "mitochondria-primed" human skin stem cells and their identification using single-cell analyses. | STAR Protoc | 2023 | 37690024 | PubTator, text mining | PubMed |
| Brain-derived neurotrophic factor protects neurons by stimulating mitochondrial function through protein kinase A. | J Neurochem | 2023 | 37688457 | PubTator, text mining | PubMed |
| Whole-Genome Sequencing Identified New Structural Variations in the DMD Gene That Cause Duchenne Muscular Dystrophy in Two Girls. | Int J Mol Sci | 2023 | 37686372 | PubTator, text mining | PubMed |
| Sodium Butyrate as Key Regulator of Mitochondrial Function and Barrier Integrity of Human Glomerular Endothelial Cells. | Int J Mol Sci | 2023 | 37685905 | PubTator, text mining | PubMed |
| Mitochondrial Dynamics in Neurodegenerative Diseases: Unraveling the Role of Fusion and Fission Processes. | Int J Mol Sci | 2023 | 37685840 | PubTator, text mining | PubMed |
| SENP5 promotes homologous recombination-mediated DNA damage repair in colorectal cancer cells through H2AZ deSUMOylation. | J Exp Clin Cancer Res | 2023 | 37684630 | PubTator, text mining | PubMed |
| Patient satisfaction survey of the "Healthy Heart" pharmaceutical care service - evaluation of pharmacy labelling with pharmaceutical pictograms. | BMC Health Serv Res | 2023 | 37679680 | PubTator, text mining | PubMed |
| Exploring a new mechanism between lactate and VSMC calcification: PARP1/POLG/UCP2 signaling pathway and imbalance of mitochondrial homeostasis. | Cell Death Dis | 2023 | 37679327 | PubTator, text mining | PubMed |
| Re-examination of therapeutic management of muscular dystrophies using a vascular smooth muscle-centered approach. | J Smooth Muscle Res | 2023 | 37673649 | PubTator, text mining | PubMed |
| HMGCS2 serves as a potential biomarker for inhibition of renal clear cell carcinoma growth. | Sci Rep | 2023 | 37670031 | PubTator, text mining | PubMed |
| Correction to: The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy. | Hum Mol Genet | 2023 | 37668344 | PubTator, text mining | PubMed |
| Elucidation of bioinformatic-guided high-prospect drug repositioning candidates for DMD via Swanson linking of target-focused latent knowledge from text-mined categorical metadata. | Front Cell Dev Biol | 2023 | 37664462 | PubTator, text mining | PubMed |
| Molecular basis of the glycosomal targeting of PEX11 and its mislocalization to mitochondrion in trypanosomes. | Front Cell Dev Biol | 2023 | 37664461 | PubTator, text mining | PubMed |
| PROCEEDINGS OF THE XXIII CONGRESS OF THE ITALIAN ASSOCIATION OF MYOLOGY: PadovaJune 8-10, 2023. | Acta Myol | 2023 | 37650038 | PubTator, text mining | PubMed |
| Intervention of pharmacist included in multidisciplinary team to reduce adverse drug event: a qualitative systematic review. | BMC Health Serv Res | 2023 | 37649018 | PubTator, text mining | PubMed |
| The Developmental Implications of Muscle-Targeted Magnetic Mitohormesis: A Human Health and Longevity Perspective. | Bioengineering (Basel) | 2023 | 37627841 | PubTator, text mining | PubMed |
| The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle. | Cells | 2023 | 37626911 | PubTator, text mining | PubMed |
| Does β-Hydroxy-β-Methylbutyrate Have Any Potential to Support the Treatment of Duchenne Muscular Dystrophy in Humans and Animals? | Biomedicines | 2023 | 37626825 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7402/papers?page=38